No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.5x · 10Y median 1.1x · 8th percentile · as of Oct 2, 2026
Annualized revenue (TTM) · by quarter, last 19
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-08-13. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
For REITs like Bluerock Homes Trust, Inc., GAAP-based multiples are shown for reference — real-estate companies are conventionally valued on funds from operations (FFO / AFFO).
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-10-01. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-02T18:40:15.901Z. Latest historical point 2026-08-13. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
For REITs like Bluerock Homes Trust, Inc., GAAP-based yields are shown for reference — real-estate companies are conventionally valued on funds from operations (FFO / AFFO).
The latest delayed quote for Bluerock Homes Trust, Inc. (BHM) stock was $8.37 as of Oct 2, 2026, 2:19 PM EDT, up 5.68% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -29.5% · 3-year avg -12.3%/yr
Bluerock Homes Trust, Inc. specializes in acquiring residential properties for investment purposes and deriving revenue from diverse real estate ventures.
REIT - Residential · New York City, NY
Bluerock Homes Trust, Inc. is a REIT, so it's valued on FFO/AFFO and price-to-FFO, not GAAP P/E — heavy non-cash property depreciation distorts reported earnings. FFO ≈ net income + real-estate depreciation; AFFO also nets recurring capital expenditure.
Next Earnings Date
Dec 2, 2026
61 days away
EPS Estimate
N/A
Revenue Est.
$19.97M
Last Quarter Results
EPS
$-0.90
vs Estimate
$0.00
Revenue
$19.33M
vs Estimate
$19.33M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BHM | $34.40M | $8.37 | +5.68% | -29.47% | N/A | N/A | N/A |
| 2SHO | $2.12B | $11.38 | +0.66% | +25.52% | +1.02% | +1.59% | vs BHM |
| 3OPEN | $2.36B | $2.45 | +2.08% | -70.25% | -34.91% | N/A | vs BHM |
| 4FRMI | $2.59B | $4.07 | +0.37% | -87.57% | N/A | N/A | vs BHM |
| 5PK | $3.12B | $15.49 | +0.49% | +51.57% | +0.95% | N/A | vs BHM |
| 6APLE | $3.88B | $16.41 | +0.27% | +45.75% | +6.50% | +4.37% | vs BHM |
Consensus Rating
Based on 1 analyst
Average Price Target
$10.00
+19.5% upside
Low
$10.00
Current
$8.37
High
$10.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Dec 2026 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Mar 2027 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Jun 2027 | $0.00 | $0.00 | $0.00 | 0 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.00 | $0.00 | $0.00 | 0 |
| FY 2027 | $0.00 | $0.00 | $0.00 | 0 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $19.97M | $19.97M | $19.97M | 1 |
| Quarter ending Dec 2026 | $20.58M | $20.58M | $20.58M | 1 |
| Quarter ending Mar 2027 | $21.20M | $21.20M | $21.20M | 1 |
| Quarter ending Jun 2027 | $21.81M | $21.81M | $21.81M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $79.58M | $79.58M | $79.58M | 1 |
| FY 2027 | $88.48M | $88.48M | $88.48M | 1 |
